Autism

News Autism

• Autism risk spotted at birth in abnormal placentas
  

  Researchers at the Yale School of Medicine have figured out how to measure an infant's risk of developing autism by looking for abnormalities in his/her placenta at birth, allowing for earlier diagnosis and treatment for the developmental disorder. The findings are reported in the April online issue more

• Blocking cell distress signals can ease autism symptoms

  Autism Speaks announced a study supported by one of Autism Speaks' first Suzanne and Bob Wright Trailblazer Awards, presents a new theory that autism may result from chronic danger signaling by mitochondria, cell structures that supply our cells with energy. This study by Trailblazer researcher and more

• Shedding new light on infant brain development
  

  A new study by Columbia Engineering researchers finds that the infant brain does not control its blood flow in the same way as the adult brain. The paper, which the scientists say could change the way researchers study brain development in infants and children, is published in Proceedings of the Nat more

Publications Autism

• Tuberous sclerosis complex regulates Drosophila neuromuscular junction growth via the TORC2/Akt pathway

  Mutations in the tuberous sclerosis complex (TSC) are associated with various forms of neurodevelopmental disorders, including autism and epilepsy. The heterodimeric TSC complex, consisting of Tsc1 and Tsc2 proteins, regulates the activity of the TOR (target of rapamycin) complex via Rheb, a small more

• Homozygous and heterozygous disruptions of ANK3: at the crossroads of neurodevelopmental and psychiatric disorders

  AnkyrinG, encoded by the ANK3 gene, is involved in neuronal development and signaling. It has previously been implicated in bipolar disorder and schizophrenia by association studies. Most recently, de novo missense mutations in this gene were identified in autistic patients. However, the causative more

• Rare exonic deletions implicate the synaptic organizer Gephyrin (GPHN) in risk for autism, schizophrenia and seizures

  The GPHN gene codes for gephyrin, a key scaffolding protein in the neuronal postsynaptic membrane, responsible for the clustering and localization of glycine and GABA receptors at inhibitory synapses. Gephyrin has well-established functional links with several synaptic proteins that have been impli more

Market studies Autism

• Autism – Pipeline Review, H2 2012

  Introduction Global Markets Direct’s, 'Autism - Pipeline Review, H2 2012', provides an overview of the Autism therapeutic pipeline. This report provides information on the therapeutic development for Autism, complete with latest updates, and special features on late-stage and discontinued projects more

• Cellceutix Pharmaceuticals, Inc. - Strategic SWOT Analysis Review

  Cellceutix Pharmaceuticals, Inc. (Cellceutix) is a publicly traded start-up bio pharmaceutical company. It is principally engaged in the development of small molecule therapies. The company primarily focuses on the treatment of cancer and inflammatory diseases. Its in-house research and development more

• Autism – Pipeline Review, H1 2012

  Introduction Global Markets Direct’s, 'Autism - Pipeline Review, H1 2012', provides an overview of the Autism therapeutic pipeline. This report provides information on the therapeutic development for Autism, complete with latest updates, and special features on late-stage and discontinued projects more

Websites Autism